Clinical trial
Electrical Impedance Myography Via the Myolex mScan as an ALS Biomarker
NCT06491732 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electrical Impedance Myography Via the Myolex mScan as an ALS Biomarker
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2025
- Completion date
- May 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.